Meditation treatment of Alzheimer disease and mild cognitive impairment: A protocol for systematic review.
Yunhui Chen, Jiayuan Zhang, Tiane Zhang, Liu Cao, Yanyan You, Chunjiang Zhang, Xinglong Liu, Qi Zhang
Medicine March 1, 2020 DOI: 10.1097/md.0000000000019313 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Clinical protocol Randomized Peer reviewed |
|---|---|
| Intervention | Meditation |
| Topics | Meditation |
| Keywords | Humans Alzheimer disease Research design Cognitive dysfunction |
| Key points | The authors propose a protocol for a systematic review to determine whether meditation is an effective and safe intervention for cognitive impairment in patients with Alzheimer disease and mild cognitive impairment. The planned review will synthesize randomized controlled trials identified through systematic searches of eight databases. |
Abstract
Background: Growing body of scientific researches in recent years have suggested the promising effect of meditation on improving cognitive impairment of Alzheimer disease (AD) and mild cognitive impairment (MCI). This paper aims to provide a protocol for systematic review to evaluate the efficacy of meditation on cognition performance of patient with AD and MCI.
Methods: The Cochrane Library, PubMed, EMBASE, Web of Science, the Chinese Biological Medicine Database, China National Knowledge Infrastructure, Wanfang database, and VIP information database will be searched systematically and electronically from establishment to March 2020. All published randomized controlled trials related will be included. Assessment of bias risk and data analyses will be implemented by Review Manager (V.5.3.5). The strength of the evidence will be assessed by the Grading of Recommendations Assessment, Development and Evaluation system.
Results: A high-quality synthesis of current evidence of meditation for patient with AD and mild cognitive impairment will be provided in this study.
Conclusion: This protocol of systematic review will be helpful for providing evidence of whether meditation is an effective and safe intervention for cognitive impairment of patient with AD and MCI. Ethics and dissemination: Ethical approval is unnecessary since this protocol is only for systematic review and does not involve privacy data or conduct an animal experiment. This protocol will be disseminated by a peer-review journal or conference presentation. Systematic review
Registration: PROSPERO CRD42019145932.
Citations in the library
Cited by 5
- Yoga an integrated mind body intervention for improvement in quality of life in individuals with Alzheimer's disease and their caregivers. Frontiers in aging 2025
- Meditation for subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Public Health 2025
- Mindfulness and meditation: Promoting emotional and cognitive health. Progress in Brain Research 2025
- A Systematic Review of the Effects of Meditation on Alzheimer's Disease Journal of Student Research November 30, 2023
- Towards the development of personalized and generalized interfaces for brain signals across different styles of meditation Indian Conference on Computer Vision, Graphics & Image Processing December 8, 2022
Cites 8
- Meditation experience is associated with increased cortical thickness Neuroreport November 7, 2005
- Cognitive-Affective Neural Plasticity following Active-Controlled Mindfulness Intervention Journal of Neuroscience October 31, 2012
- Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: Results of a randomized clinical trial Arthritis Care & Research January 31, 2007
- Meditation's impact on chronic illness. Holistic Nursing Practice 2003
- Cerebral blood flow differences between long-term meditators and non-meditators. Consciousness and Cognition December 2010
and 3 more in the library